Nadège Bercovici

3.5k total citations · 1 hit paper
42 papers, 2.5k citations indexed

About

Nadège Bercovici is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Nadège Bercovici has authored 42 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 15 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Nadège Bercovici's work include Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (18 papers). Nadège Bercovici is often cited by papers focused on Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (18 papers). Nadège Bercovici collaborates with scholars based in France, United States and Belgium. Nadège Bercovici's co-authors include Alain Trautmann, Marion V. Guérin, Roland Liblau, Emmanuel Donnadieu, Lene Vimeux, Elisa Peranzoni, Jérôme Delon, Vincent Feuillet, Fabienne Régnier and Diane Damotte and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Nadège Bercovici

42 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment

2018 631 citations Elisa Peranzoni, Lene Vimeux et al. profile →

Peers

Countries citing papers authored by Nadège Bercovici

Since Specialization

Citations

This map shows the geographic impact of Nadège Bercovici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Bercovici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Bercovici more than expected).

Fields of papers citing papers by Nadège Bercovici

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Bercovici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Bercovici. The network helps show where Nadège Bercovici may publish in the future.

Co-authorship network of co-authors of Nadège Bercovici

This figure shows the co-authorship network connecting the top 25 collaborators of Nadège Bercovici. A scholar is included among the top collaborators of Nadège Bercovici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadège Bercovici. Nadège Bercovici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novae: a graph-based foundation model for spatial transcriptomics data 2025 ·Nature Methods ·(unknown), (unknown), Nadège Bercovici, Kevin Mulder, Grégoire Gessain, Florent Ginhoux, Fabrice André, Paul-Henry Cournède	1
2	A biology-driven deep generative model for cell-type annotation in cytometry 2023 ·Briefings in Bioinformatics ·(unknown), Nadège Bercovici, Charles‐Antoine Dutertre, Isabelle Pic, Joana Ribeiro, Fabrice André, Paul-Henry Cournède	4
3	CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1 2021 ·Cancer Immunology Research ·Chahrazade Kantari‐Mimoun, Sarah Barrin, Lene Vimeux, (unknown), Claire Gervais, (unknown), (unknown), Nadine Mockel-Tenbrinck, Ali Kinkhabwala, Diane Damotte, Audrey Lupo, Mathilde Sibony, Marco Alifano, Elisabetta Dondi, Nadège Bercovici, Alain Trautmann, Andrew Kaiser, Emmanuel Donnadieu	51
4	Preclinical murine tumor models: A structural and functional perspective 2020 ·eLife ·Marion V. Guérin, Veronica Finisguerra, Benoı̂t J. Van den Eynde, Nadège Bercovici, Alain Trautmann	92
5	Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse 2020 ·Journal for ImmunoTherapy of Cancer ·Marion V. Guérin, Fabienne Régnier, Maxime Thoreau, Lene Vimeux, (unknown), Estelle Dransart, Hweixian Leong Penny, Ludger Johannes, Alain Trautmann, Nadège Bercovici	2
6	Blockade of β-Adrenergic Receptors Improves CD8+ T-cell Priming and Cancer Vaccine Efficacy 2019 ·Cancer Immunology Research ·(unknown), Lene Vimeux, (unknown), Elisa Peranzoni, Georges Bismuth, Élisabeth Wieduwild, Bruno Lucas, Emmanuel Donnadieu, Nadège Bercovici, Alain Trautmann, Vincent Feuillet	60
7	TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors 2019 ·Nature Communications ·Marion V. Guérin, Fabienne Régnier, Vincent Feuillet, Lene Vimeux, Julia Miriam Weiss, Georges Bismuth, Grégoire Altan‐Bonnet, Thomas Guilbert, Maxime Thoreau, Veronica Finisguerra, Emmanuel Donnadieu, Alain Trautmann, Nadège Bercovici	43
8	A Fluorescent Nanoprobe for the Detection of in Situ Temperature Changes during Hyperthermia Treatment of Tumors 2018 ·Biophysical Journal ·Edouard Alphandéry, Darine Abi Haidar, Olivier Seksek, Maxime Thoreau, Alain Trautmann, Nadège Bercovici, Florence Gazeau, François Guyot, Imène Chebbi	1
9	Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy 2011 ·Clinical Cancer Research ·Giulia Fregni, Aurélie Perier, Gianfranco Pittari, (unknown), Xavier Sastre, Nadine Gervois, Mathilde Allard, Nadège Bercovici, (unknown), Anne Caignard	48
10	Progressive Upregulation of PD-1 in Primary and Metastatic Melanomas Associated with Blunted TCR Signaling in Infiltrating T Lymphocytes 2011 ·Journal of Investigative Dermatology ·(unknown), Clotilde Randriamampita, E. Maubec, Cécile Badoual, Stéphane Fouquet, Shufang Wang, Eduardo Marinho, David Farhi, Marylène Garcette, (unknown), Alexandre Rouquette, A. Carlotti, Angélique Girod, Armelle Prévost‐Blondel, Alain Trautmann, Marie‐Françoise Avril, Nadège Bercovici	69
11	Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma 2010 ·Journal of Translational Medicine ·Antoni Ribas, Luis H. Camacho, Sun Min Lee, Evan M. Hersh, Charles K. Brown, Jon Richards, (unknown), Víctor G. Prieto, John A. Glaspy, Denise K. Oseguera, Jackie Hernandez, Arturo Villanueva, Bartosz Chmielowski, (unknown), Nadège Bercovici, Ernesto Wasserman, D Landais, Merrick I. Ross	29
12	Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients 2008 ·Journal of Immunotherapy ·Nadège Bercovici, Nacilla Haicheur, (unknown), Frédérique Vernel-Pauillac, Olivier Adotévi, D Landais, Isabelle Gorin, Caroline Robert, H. Miles Prince, Jean‐Jacques Grob, M.‐T. Leccia, Thierry Lesimple, John Wijdenes, Jacques Bartholeyns, Wolf H. Fridman, Margarita Salcedo, (unknown), Éric Tartour	56
13	Vaccination of Metastatic Colorectal Cancer Patients With Matured Dendritic Cells Loaded With Multiple Major Histocompatibility Complex Class I Peptides 2007 ·Journal of Immunotherapy ·Brian D. Kavanagh, Andrew H. Ko, Alan P. Venook, Kim Margolin, Herbert J. Zeh, Michael T. Lotze, Brian Schillinger, Weihong Liu, Ying Lü, (unknown), M Schilling, Nadège Bercovici, Maureen Loudovaris, (unknown), Sun Min Lee, James Bender, Bonnie Mills, Lawrence Fong	83
14	An Altered Self-Peptide with Superagonist Activity Blocks a CD8-Mediated Mouse Model of Type 1 Diabetes 2004 ·The Journal of Immunology ·Agnès Hartemann–Heurtier, Lennart T. Mars, Nadège Bercovici, Sabine Desbois, (unknown), Eliane Piaggio, Jacques Zappulla, Abdelhadi Saoudi, Roland Liblau	22
15	Use of Cell-Tracking Dyes to Determine Proliferation Precursor Frequencies of Antigen-Specific T Cells 2004 ·Humana Press eBooks ·Alice L. Givan, Jan L. Fisher, Mary Waugh, Nadège Bercovici, Paul K. Wallace	31
16	Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA 2004 ·Cancer Immunology Immunotherapy ·Benoı̂t Barrou, G Benoît, Mahmoud Ould-Kaci, Olivier Cussenot, Margarita Salcedo, Sudhanshu Agrawal, (unknown), Nadège Bercovici, (unknown), Nicolas Thiounn	63
17	Delayed and Separate Costimulation In Vitro Supports the Evidence of a Transient “Excited” State of CD8+ T Cells During Activation 2000 ·The Journal of Immunology ·Nathalie Pardigon, (unknown), Nadège Bercovici, Fabrice Lemaı̂tre, Roland Liblau, Philippe Kourilsky	6
18	Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage 2000 ·The Journal of Immunology ·Nadège Bercovici, A. Heurtier, Csaba Vízler, Nathalie Pardigon, (unknown), Pierre Desreumaux, Roland Liblau	20
19	Enrichment of antigen-specific T lymphocytes by panning on immobilized MHC–peptide complexes 1997 ·Immunology Letters ·Philippe Bousso, Frédérique Michel, Nathalie Pardigon, Nadège Bercovici, Roland Liblau, Philippe Kourilsky, Jean‐Pierre Abastado	8
20	Systemic antigen in the treatment of T-cell-mediated autoimmune diseases 1997 ·Immunology Today ·Roland Liblau, Roland Tisch, Nadège Bercovici, Hugh O. McDevitt	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact